ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $690,000 | -77.1% | 14,866 | -88.0% | 0.00% | -80.0% |
| Q1 2019 | $3,014,000 | +128.2% | 124,128 | +32.6% | 0.02% | +100.0% |
| Q4 2018 | $1,321,000 | -6.4% | 93,635 | +0.5% | 0.01% | 0.0% |
| Q3 2018 | $1,411,000 | +251.9% | 93,199 | +289.2% | 0.01% | +233.3% |
| Q2 2018 | $401,000 | -8.4% | 23,945 | -11.6% | 0.00% | -25.0% |
| Q1 2018 | $438,000 | +160.7% | 27,090 | +107.3% | 0.00% | +300.0% |
| Q4 2017 | $168,000 | -50.3% | 13,065 | -53.0% | 0.00% | -66.7% |
| Q3 2017 | $338,000 | +259.6% | 27,787 | +136.5% | 0.00% | +200.0% |
| Q4 2016 | $94,000 | -80.9% | 11,750 | -89.1% | 0.00% | -88.9% |
| Q2 2014 | $493,000 | -4.5% | 108,170 | -1.5% | 0.01% | -10.0% |
| Q1 2014 | $516,000 | +1.4% | 109,790 | +8.1% | 0.01% | 0.0% |
| Q4 2013 | $509,000 | – | 101,552 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,556,586 | $215,946,000 | 10.65% |
| BVF INC/IL | 6,402,525 | $78,751,000 | 10.01% |
| First Light Asset Management, LLC | 1,469,461 | $18,074,000 | 5.72% |
| Avoro Capital Advisors LLC | 5,353,029 | $65,842,000 | 5.11% |
| EcoR1 Capital, LLC | 1,250,000 | $15,375,000 | 2.05% |
| Cormorant Asset Management, LP | 900,000 | $11,070,000 | 1.96% |
| NEXTHERA CAPITAL LP | 615,437 | $7,570,000 | 1.95% |
| Monashee Investment Management LLC | 418,000 | $5,141,000 | 1.94% |
| Orbimed Advisors | 14,182,900 | $174,450,000 | 1.67% |
| KOPP INVESTMENT ADVISORS LLC | 119,579 | $1,471,000 | 1.35% |